PCI Biotech
CONTACT US
ABOUT PCI BIOTECH BOARD OF DIRECTORS MANAGEMENT COMPANY PRESENTATION
TECHNOLOGY PIPELINE PARTNERING
INVESTORS NEWS REPORTS AND PRESENTATIONS SHARE INFORMATION GENERAL MEETING INFORMATION FINANCIAL CALENDAR CORPORATE GOVERNANCE AND CSR NOMINATION COMMITTEE
ABOUT US ABOUT PCI BIOTECH BOARD OF DIRECTORS MANAGEMENT COMPANY PRESENTATION WHAT WE DO TECHNOLOGY PIPELINE PARTNERING INVESTORS INVESTORS NEWS REPORTS AND PRESENTATIONS SHARE INFORMATION GENERAL MEETING INFORMATION FINANCIAL CALENDAR CORPORATE GOVERNANCE AND CSR NOMINATION COMMITTEE CONTACT US
PCI Biotech
 

NEWS

News archive
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
 
PCI Biotech to present at BIO-Europe 2019
NewsRonny SkuggedalNovember 12, 2019
PCI Biotech to present at World Vaccine Congress Europe
NewsRonny SkuggedalOctober 28, 2019
PCI Biotech is hiring a Chief Medical Officer and a Chief Business Officer
NewsRonny SkuggedalOctober 9, 2019
Capital increase registered and listing of new shares
NewsRonny SkuggedalSeptember 9, 2019
Mandatory notification regarding trade of shares
NewsRonny SkuggedalAugust 30, 2019
Second quarter and first half 2019 results
NewsRonny SkuggedalAugust 28, 2019
Invitation to second quarter and first half 2019 results presentation
NewsRonny SkuggedalAugust 20, 2019
Extension of preclinical research collaboration agreement with a top-10 large pharma company
NewsRonny SkuggedalJuly 22, 2019
PCI Biotech to present at IPA World Congress
NewsRonny SkuggedalJuly 3, 2019
Employee share option scheme
NewsRonny SkuggedalJune 21, 2019
Minutes from Annual General Meeting 2019
NewsRonny SkuggedalMay 29, 2019
First patient enrolled in the fimaChem pivotal RELEASE study
NewsRonny SkuggedalMay 23, 2019
Notice of Annual General Meeting 2019
NewsRonny SkuggedalMay 8, 2019
First quarter 2019 results
NewsRonny SkuggedalMay 8, 2019
Successful clinical translation of the fimaVACC technology
NewsRonny SkuggedalMay 3, 2019
Invitation to first quarter 2019 result presentation
NewsRonny SkuggedalApril 30, 2019
Annual Report 2018
NewsRonny SkuggedalApril 9, 2019
Final confirmation of successful safety read-out in the Phase I Extension study
NewsRonny SkuggedalApril 8, 2019
Resignation of Chief Business Development Officer
NewsRonny SkuggedalFebruary 28, 2019
Capital increase registered and listing of new shares
NewsRonny SkuggedalFebruary 25, 2019
Newer Older

Privacy policy I Contact us
©COPYRIGHT PCI BIOTECH. ALL RIGHTS RESERVED